Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Impedimed Limited ( (AU:IPD) ) just unveiled an update.
Impedimed Limited announced a proposed issue of securities, with a maximum of 12,491,870 warrants set to be issued. This strategic move aims to bolster the company’s financial position, potentially enhancing its operational capabilities and market competitiveness within the medical technology industry.
More about Impedimed Limited
Impedimed Limited operates within the medical technology industry, primarily focusing on the development of non-invasive medical devices for the assessment of fluid status and body composition. These devices serve various sectors within the healthcare market, including oncology, renal and heart failure management, and lymphedema diagnosis.
YTD Price Performance: -10.0%
Average Trading Volume: 33,136
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $64.61M
See more insights into IPD stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue